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Introduction
!
The adenoma detection rate (ADR) is the primary
measure of the quality of mucosal inspection dur-
ing colonoscopy [1,2]. Higher ADRs predict better
protection against colorectal cancer [3,4]. In addi-
tion to the ADR, there is interest in the measure-
ment of adenomas detected per colonoscopy
(APC) as a quality measure [2,5]. The ADR and
APC correlate in some but not all centers [6]. Ade-
quate ADR with low APC may reflect a “one-and-
done” manipulation of ADR, so that in some set-
tings APC or a similar measure may be a better re-
flection of the quality of mucosal inspection than
ADR [2,5–7].
Technologies including narrow-band imaging
(NBI; Olympus America Corp., Center Valley,
Pennsylvania, USA), confocal laser microscopy,
endocytoscopy, autofluorescence, the Fujinon
Intelligent Chromoendoscopy system (Fujifilm
Medical Systems, Wayne, New Jersey, USA), and
the Pentax i-scan (Pentax Medical, Montvale,
New Jersey, USA) have been shown to allow accu-
rate estimation of pathology in colorectal polyps
in real time [8,9]. Two practical roles for these
technologies have been proposed [9,10]. The first
role is within the policy of “resect and discard,” in
which diminutive or small polyps, for which the
pathology is predicted by endoscopy with high
confidence, are resected and then discardedwith-
out pathologic assessment [9–12]. Modeling in-
dicates that the resect and discard policy is cost
effective [13,14]. A second proposed role is to
identify diminutive rectosigmoid polyps as hy-
perplastic and then leave them in place, thereby
avoiding the costs of both polypectomy and
pathologic assessment [9]. This paradigm was
proposed by the American Society for Gastroin-
testial Endoscopy (ASGE) [9], and endorsed by
the European Society for Gastrointestinal Endos-
copy [10].
Given that measurement of ADR and perhaps APC
(in the future) are important to high quality colo-
noscopy, the introduction of resect and discard
could create a problem for quality measurements,
as some diminutive polyps would not be available
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Background and study aims: The adenoma detec-
tion rate (ADR) and adenomas detected per colo-
noscopy (APC) are measures of the quality of mu-
cosal inspection during colonoscopy. In a resect
and discard policy, pathologic assessment for cal-
culation of ADR and APC would not be available.
The aim of this study was to determine whether
ADR and APC calculation based on photography
alone is adequate compared with the pathology-
based gold standard.
Patients and methods: A prospective, observa-
tional, proof-of-concept study was performed in
an academic endoscopy unit. High definition pho-
tographs of consecutive polyps were taken, and
pathology was estimated by the colonoscopist.
Among 121 consecutive patients aged ≥50 years
who underwent colonoscopy, 268 polyps were
removed from 97 patients. Photographs of conse-
cutive polyps were reviewed by a second endos-
copist.
Results: The resect and discard policy applied to
lesions that were≤5mm in size. When only pho-
tographs of lesions that were ultimately proven to
be adenomas were included, the reviewer asses-
sed ADR and APC to be lower than that deter-
mined by pathology (absolute reductions of 6.6%
and 0.17, and relative reductions of 12.6% and
13.1% in ADR and APC, respectively). When all
photographs were included for calculation of
ADR and APC, the reviewer determined the ADR
to be 3.3% lower (absolute reduction) and the
APC to be the same as the rates determined by pa-
thology.
Conclusions: In a simulated resect and discard
strategy, a high-level detector can document ade-
quate ADR and APC by photography alone.
for pathologic assessment and documentation of adenomas. The
ASGE addressed this issue in its Preservation and Incorporation
of Valuable Endoscopic Innovations document on real-time pa-
thology assessment of colorectal polyps [9]. The ASGE indicated
that the use of imaging technologies for real-time assessment
must be accompanied by stored images that are of sufficient
quality to create a permanent record of the basis on which the
endoscopist’s real-time decision was made [9]. Thus, high quali-
ty, permanently stored photographs or video recordings are the
likely solution to the lack of pathology data in a resect and discard
program.
Stored images of polyps are also one solution to avoiding the ex-
cess pathology costs associated with APC measurement. For ex-
ample, if three separate adenomas are seen and removed from
the same section of the colon, then a photograph of each polyp
would prove their multiplicity for APC measurement. The three
polyps could then be placed in the same bottle for pathology as-
sessment, or potentially discarded in a resect and discard pro-
gram.
To our knowledge, no previous study of using endoscopic ima-
ging has included demonstration of adequate ADR and APC as its
primary focus. In a resect and discard practice, endoscopists
would refer polyp photographs for review by other expert endos-
copists to prove that their ADR and APC met recommended
thresholds for detection. The aim of the current study was to as-
sess whether a known high level detector with experience in
real-time diagnosis could use photography in consecutive exam-
inations to document adequate ADR and APC.
Methods
!
Design and patients
This prospective assessment of photography and its adequacy for
documentation of ADR and APC was approved by the Indiana
University Institutional Review Board.
A single colonoscopist (D.K.R.) with a proven high ADR (47%–
58% in two screening colonoscopy studies) [11, 15,16] acquired
endoscopic images of all resected polyps from 121 consecutive
colonoscopies during a 6-week period. The colonoscopist also
had proven high accuracy (89%–94% overall accuracy and 94%–
98% for high confidence readings in two studies) in real-time es-
timation of colorectal polyp histology using NBI [11,17].
Patients were included if they were aged 50 years or over. Pa-
tients were excluded if they had inflammatory bowel disease,
previous colonic resection, a known polyposis syndrome, or
were referred for resection of a large polyp identified by another
endoscopist.
Image assessment
All polyp images were acquired using NBI and 180 series colono-
scopes (Olympus America Corp.). For each polyp, the colonosco-
pist froze an image until a satisfactory image for capture and sto-
rage was obtained. Electronic magnification was used at the dis-
cretion of the colonoscopist. The colonoscopist estimated polyp
pathology in real time using the Narrow band imaging Interna-
tional Colorectal Endoscopic classification (NICE) criteria [18].
Confidence in interpretation was assigned as high or low in real
time. Polyp size was estimated by the colonoscopist using the
longest apparent dimension of the polyp. In some cases, the
polypwas sized using open forceps. The size estimated by the co-
lonoscopist was used to assign polyps to size groups in order to
assess the accuracy of the colonoscopist and the reviewer. Polyps
were resected using standard techniques and sent for pathologic
assessment.
Calculation of ADR and APC
ADR was the proportion of patients having one or more adeno-
mas in the colon. APC was the total number of adenomas in all
study colonoscopies divided by the total number of study colo-
noscopies.
ADR and APC were calculated according to: the determination
made by the pathologist; the estimation of pathology made in
real time during colonoscopy; and the review of stored photo-
graphs by the second endoscopist (reviewer) using NICE criteria
[18].
The second endoscopist was an experienced colonoscopist who
had authored a number of clinical studies of colonoscopy, had
completed a training program in NBI [19], and reported using
NBI in clinical practice in hundreds of cases with feedback from
routine pathology reports. However, the second endoscopist’s ac-
curacy in optical biopsy had not been proven in a previous pub-
lished clinical trial. No clinical information was provided to the
reviewer. Thus, the reviewer was unaware of the number of
polyps removed from each patient, the location of polyps in the
colon, or their size or histology as estimated by the primary colo-
noscopist. High definition images in TIF format were displayed on
a high definition monitor for the review. Each pathology estima-
tion was also characterized as a high or low confidence interpre-
tation. No photographs were considered by the reviewer to be of
insufficient quality to make a pathology estimation.
The ADR and APC were calculated first by counting lesions veri-
fied by pathology as adenomas and then by using all adenoma
guesses from the colonoscopist and the reviewer irrespective of
pathology verification. It was assumed that polyps in the size ca-
tegories of 6–9mm and ≥10mm would be sent for pathology
(and the pathology report would be used to determine the con-
tribution to ADR and APC), while smaller lesions (≤5mm) would
be interpreted by the colonoscopist and the reviewer. Results are
presented with the ADR and APC calculated when only the high
confidence interpretations of small polyps by the colonoscopist
were counted toward ADR and APC, with histology being used
to identify adenomas among small polyps interpreted with low
confidence by the colonoscopist. Results are also presented with
the colonoscopist’s estimations of pathology used for all small
polyps regardless of the confidence rating, as some endoscopists
might interpret all polyps of small size with high confidence.
Statistical analysis
The sample size calculationwas performed using Stata version 13
(StataCorp, College Station, Texas, USA). Assuming a prevalence
of adenomas of 50%, 97 patients were needed to determine
ADRs within a 95% confidence range of ±10 percentage points at
80% power. The agreement between the endoscopist and the re-
viewer was measured using Cohen’s kappa. For this analysis, the
234 polyps for which the colonoscopist’s estimate of pathology
matched the gold standard of pathology were used. Assuming
that the agreement between the colonoscopist and the reviewer
would be moderate (0.5), a sample size of 234 polyps provided a
95% confidence interval of 0.1 around the measured kappa value.
The 95% confidence intervals for the ADR were calculated using
the equation
p ± 1.96 √[p(1–p)/n]
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where p is the ADR point estimate and n is the number of proce-
dures.
The 95% confidence intervals for APC were calculated using the
formula
x ± 1.96 (SD/√n)
where x is the APC point estimate and SD is the standard devia-
tion of the number of adenomas detected per colonoscopy [20].
The proportion of readings with high confidence and the accura-
cy were compared between the colonoscopist and the reviewer
using a two-sided chi-squared test. Statistical significance was
set at 0.05.ADR, APC calculations, chi-squared tests, and Cohen’s
kappa measurement were performed using SPSS version 20 (IBM
Inc., Armonk, New York, USA).
Results
!
A total of 121 consecutive patients aged ≥50 years met the elig-
ibility criteria and were included in the study. The mean age was
64.7 years, and there were 67 women (55.4%). The indications
were polyp surveillance in 79 (65.3%), screening in 28 (23%),
and diagnostic in 14 (11.6%). There were 97 patients with at least
one polyp removed, and 63with at least one conventional adeno-
ma (not including patients with only sessile serrated polyp/ade-
noma [SSA/P]). A total of 268 polyps or flat lesions were removed
from the 97 patients, and the histology of the lesions as deter-
mined by the pathologist is shown in●" Table1. In addition, one
cancer was found in an overt mass (recognized as cancer by the
endoscopist and the reviewer).
●" Table2 shows the accuracy of the colonoscopist and reviewing
endoscopist assessments compared with pathology on a per-
polyp basis. The colonoscopist interpreted a smaller percentage
of all lesions with high confidence compared with the reviewer
(88% vs. 94%; P=0.109). For all lesions (regardless of size) read
with high confidence by both the colonoscopist and the reviewer,
the colonoscopist had higher accuracy than the reviewer (92% vs.
83%; P<0.001). This differencewas driven largely by higher accu-
racy for lesions of ≤5mm in size (89% vs. 80%; P<0.001). For le-
sions interpreted with high confidence by the colonoscopist, the
kappa value for the agreement between the colonoscopist and
the reviewer was 0.619 for lesions 1–5mm in size, 0.617 for le-
sions 6–9mm in size, and 0.9 for lesions ≥10mm in size.
Using the histology determined by the pathologist as the gold
standard, the ADR for the 121 patients was 52.1% and the APC
was 1.30 (●" Table3,●" Table4).
●" Table3 shows the ADRs and APCs determined by the colonos-
copist and the reviewer, according to the confidence readings and
including only those adenomas that were verified by the pathol-
ogist. ●" Table4 shows the same data but includes all lesions
called adenomas by the colonoscopist and reviewer without re-
ference to the pathologist interpretation (i. e. some of the endos-
copist and reviewer adenoma readings would be false-positive
results).●" Table3 and●" Table4 show the ADR and APC if the re-
sect and discard policy was expanded to polyps in the 6–9-mm
size range [12].
When only pathologist-verified adenomas are counted toward
ADR and APC (●" Table3), the calculated ADR and APC rates were
all numerically less than the pathologically determined ADR and
APC. In the United States, the use of photography would be for le-
sions ≤5mm in size evaluated with high confidence. In this situa-
tion, the reviewer established an ADR for the colonoscopist of
45.4% and an APC of 1.13. These are absolute reductions of 6.6%
and 0.17, and relative reductions of 12.6% and 13.1% in ADR and
Table 1 Pathology findings by lesion size (n = 268 lesions).
Lesion size, mm Adenoma, n (%)1 Hyperplastic and other serrated, n (%)1 Other2, n (%)1
≤5 109 (59.2) 54 (29.3) 21 (11.4)
6–9 36 (58.1) 26 (41.9) 0 (0)
≥10 12 (54.5) 8 (36.4) 2 (9.1)
Total 157 (58.6) 88 (32.8) 23 (8.6)
1 Percentages calculated as proportion of lesion size group.
2 Other consists of 13 normal tissue, 1 inflammatory, 9 not retrieved or fecal matter only recovered.
Table 2 Accuracy of interpretations by the colonoscopist and the reviewer compared with pathology – all polyps.
High and low confidence readings High confidence readings only
Adenomas interpreted as
adenomas, n (%) [95%CI]
Nonadenomas interpreted as
nonadenomas, % [95%CI]
Adenomas interpreted as
adenomas, % [95%CI]
Nonadenomas interpreted as
nonadenomas, % [95%CI]
All lesions
Colonoscopist 150 (95.5) [92.3–98.8] 81 (79.4) [71.6–87.3] 134 (96.4) [93.3–99.5] 75 (83.3) [75.6–91]
Reviewer 132 (84.1) [78.4–89.8] 74 (72.5) [63.9–81.2] 127 (85.8) [80.2–91.4] 71 (74.7) [66–83.5]
Lesions≥10mm
Colonoscopist 11 (91.7) [76–100] 9 (100) [N/A] 10 (90.9) [73.9–100] 9 (100) [N/A]
Reviewer 11 (91.7) [76–100] 8 (88.9) [68.4–100] 11 (100) [N/A] 8 (88.9) [68.4–100]
Lesions 6–9mm
Colonoscopist 33 (91.7) [82.6–100] 26 (100) [N/A] 32 (94.1) [86.2–100] 25 (100) [N/A]
Reviewer 34 (94.4) [87–100] 19 (73.1) [56–90.1] 33 (97.1) [91.4–100] 18 (78.3) [61.4–95.1]
Lesions≤5mm
Colonoscopist 106 (97.2) [94.2–100] 46 (68.7) [57.6–79.8] 92 (97.9) [95–100] 41 (73.2) [61.6–84.8]
Reviewer 87 (79.8) [72.3–87.4] 47 (70.1) [59.2–81.1] 83 (80.6) [72.9–88.2] 45 (71.4) [60.3–82.6]
N/A, not applicable.
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APC, respectively, compared with the ADR and APC determined
by pathologic assessment of all polyps.
●" Table4 shows how photographywould represent ADR and APC
in a post-credentialing phase, as lesions that are false-positive
adenoma interpretations would still be counted toward ADR
and APC. Under these circumstances, the ADR determined by
the reviewer was 48.8% (absolute reduction of 3.3% from the pa-
thology-based ADR) and the APC was 1.31, which is almost iden-
tical to the APC determined by pathology (●" Table4).
Discussion
!
This study prospectively evaluated whether an expert colonosco-
pist could utilize photography during colonoscopy to establish
adequate rates of adenoma detection. When the colonoscopist’s
skill at interpreting adenomas was assessed against pathological-
ly proven adenomas, there was about a 13% relative reduction in
ADR and APC (compared with the pathologically determined
ADR and APC; absolute reductions of 6.6% and 0.17, respectively),
as determined by an experienced reviewer assessing the endo-
scopic photographs. This suggests that for a colonoscopist to use
photography, and establish competence during a validation or
credentialing phase, the colonoscopist’s “true” ADR as deter-
mined by pathology would need to be somewhat higher than
the minimum target ADR of 20% [2]. Assuming a target ADR of
20% to establish competent mucosal inspection by any colonos-
copist, and an approximately 13% reduction in ADR with photo-
graphy, colonoscopists with “true ADRs” of ≥24% should be able
to utilize photography to demonstrate adequate ADR. In reality,
many colonoscopists have true ADRs substantially above current
targets, and therefore should be able to easily establish adequate
an ADR using photography. Similar arguments can be put for-
ward regarding the use of APC as a target. A recent study found
strong correlation between ADR and APC, and suggested that an
APC of 0.5 for males and 0.2 for females, corresponds to the cur-
rent targets for ADR [21].
Table 3 Adenoma detection rate
and adenomas per colonoscopy –
pathologically confirmed adeno-
mas only.
ADR, % [95%CI] APC [95%CI]
Determined by pathology 52.1 [43.2–61] 1.30 [0.96–1.64]
Determined by using endoscopy estimates for high confidence readings of
polyps≤5mm in size, pathology for polyps≥6mm in size or for polyps≤5mm
in size with low confidence
Colonoscopist 51.2 [42.3–60.1] 1.28 [0.8–1.46]
Reviewer 45.5 [36.6–54.4] 1.13 [0.8–1.46]
Determined by using endoscopy estimates for both high and low confidence
readings of polyps≤5mm and pathology for polyps≥6mm
Colonoscopist 51.2 [42.3–60.1] 1.27 [0.93–1.61]
Reviewer 44.6 [35.7–53.5] 1.12 [0.79–1.44]
Determined by using endoscopy estimates for high confidence readings of
polyps < 10mm in size, and pathology for polyps≥10mm in size or for polyps
< 10mm in size with low confidence
Colonoscopist 51.2 [42.3–60.1] 1.26 [0.92–1.6]
Reviewer 45.5 [36.6–54.4] 1.12 [0.8–1.45]
Determined by using endoscopy estimates for both high and low confidence
readings of polyps <10mm in size, pathology for polyps≥10mm in size
Colonoscopist 50.4 [41.5–59.3] 1.25 [0.91–1.59]
Reviewer 44.6 [35.7–53.5] 1.1 [0.77–1.42]
ADR, adenoma detection rate; APC, adenomas per colonoscopy.
Table 4 Adenoma detection rate
and adenomas per colonoscopy –
using all endoscopy estimates
irrespective of pathology reading.
ADR, % [95%CI] APC [95%CI]
Determined by pathology 52.1 [43.2–61] 1.30 [0.96–1.64]
Determined by using endoscopy estimates for high confidence readings of
polyps≤5mm in size, pathology for polyps≥6mm in size or for polyps≤5mm
in size with low confidence
Colonoscopist 55.4 [46.5–64.3] 1.43 [1.07–1.79]
Reviewer 49.6 [40.7–58.5] 1.31 [0.96–1.67]
Determined by using endoscopy estimates for both high and low confidence
readings of polyps≤5mm and pathology for polyps≥6mm
Colonoscopist 57 [48.2–65.8] 1.49 [1.12–1.85]
Reviewer 48.8 [39.9–57.7] 1.31 [0.96–1.67]
Determined by using endoscopy estimates for high confidence readings of
polyps < 10mm in size, and pathology for polyps≥10mm in size or for polyps
< 10mm in size with low confidence
Colonoscopist 55.4 [46.5–64.3] 1.41 [1.05–1.78]
Reviewer 51.2 [42.3–60.1] 1.35 [0.98–1.71]
Determined by using endoscopy estimates for both high and low confidence
readings of polyps <10mm in size, pathology for polyps≥10mm in size
Colonoscopist 56.2 [47.4–65] 1.46 [1.1–1.83]
Reviewer 51.2 [42.3–60.1] 1.36 [0.99–1.72]
ADR, adenoma detection rate; APC, adenomas per colonoscopy.
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The current study found that when photography was used to de-
monstrate ADR and APC without reference to pathology, as it
would likely be when implemented in clinical practice, the colo-
noscopist’s calculation of ADR and APC sometimes numerically
exceeded the pathologically determined ADR and APC, though
the differences were minor. It is possible that for some polyps,
the colonoscopist’s assessment can provide better information
than pathology: in some cases polyps may not be retrieved, or
very small adenomas may be removed by cold snaring and sent
for pathology where they may be inaccurately characterized as
“normal” because the polyp was not sectioned through the ade-
noma tissue in the pathology laboratory [11].
The concept presented in this study has implications for endo-
scopic electronic report-generating systems and electronic
health records. As resect and discard enters clinical practice, co-
lonoscopists and quality improvement programs will demand
that reporting systems allow storage of images of the same qual-
ity and resolution as the real-time images that led to the original
endoscopic estimation of pathology. These images will also be
needed to provide medical-legal protection for colonoscopists,
whichmay be needed if patients subsequently develop colorectal
cancer.
The colonoscopist and the reviewer in the current study utilized
the NICE criteria [18] to classify polyps. The NICE criteria can be
used to differentiate conventional adenomas from polyps in the
serrated class, but neither the NICE criteria nor any other endo-
scopic criteria have been reliably shown to differentiate polyps
within the serrated class as hyperplastic vs. SSA/Ps. Similarly,
the NICE criteria do not allow identification within conventional
adenomas of the degree of dysplasia or villous vs. tubular ele-
ments. This lack of information about conventional adenomas is
managed in the resect and discard paradigm by confining endo-
scopic estimations to polyps ≤5mm in size. Polyps of this size
have a very low prevalence of villous elements, high grade dys-
plasia, or cancer [22]. The lack of information about hyperplastic
vs. SSA/P histology can be similarly managed by confining endo-
scopic estimation to lesions≤5mm in size, as the prevalence of
SSA/P in lesions of this size is very low [23]. Alternatively, colo-
noscopists could send serrated lesions of ≤5mm in size in the
proximal colon to pathology. Either management strategy can
be incorporated into a resect and discard paradigm.
One concern in establishing detection targets is the potential for
any target to be manipulated, and this has been observed in clin-
ical practice [6]. In a photography-based system for documenta-
tion of ADR or APC, a photograph of each polyp serves as a substi-
tute for a glass slide stored in the pathology department as the
record of the polyp [9]. This system would seem to be resistant
to manipulation, but developers of image storage systems and
managers of quality improvement programs should direct their
development of photography-based ADR to systems that cannot
be manipulated.
Limitations of the current study include that it was performed by
a single expert colonoscopist and reviewed by a single experi-
enced endoscopist, and both the colonoscopist and the reviewer
had extensive experience in NBI. However, this proof-of-concept
study demonstrates the feasibility and reasonable accuracy of
ADR and APC documentation by photography. The calculated
ADR and APC were not substantially affected by use of only high
confidence vs. high+low confidence readings. The colonoscopist
had higher accuracy for determining pathology than the review-
er, perhaps because of greater experience or evaluation in real
time rather than by still photographs, or because of the very lim-
ited clinical information about each polyp (e.g. location in the co-
lon) provided to the reviewer. This difference is also a strength of
the study, as it indicates that a high-level detector can demon-
strate adequate ADR and APC when his/her polyp photographs
are studied by reviewers with a range of polyp differentiation ex-
perience and skills, as might often occur in clinical practice.
A second limitation is that the study population was largely sur-
veillance patients, and ADR is typically higher (about 7%) in sur-
veillance patients compared with screening patients [21]. How-
ever, the colonoscopist in the current study had twice previously
demonstrated ADRs in screening patients that were higher than
the 52% ADR demonstrated in the current study [15,24]. Further-
more, there is no indication that the surface features of colorectal
polyps in screening patients differ from those in surveillance pa-
tients.
In conclusion, these findings suggest that under a wide range of
assumptions, high-level detectors should have little difficulty
documenting adequate ADR and APC using photography of colo-
rectal polyps. Difficulty in documentation of ADR is an argument
against a resect and discard policy. Although many studies have
evaluated NBI [25] and other technologies [25,26], this study is,
to our knowledge, the first to directly address whether photogra-
phy can support ADR and APC documentation. ADR and APC de-
termination using photography alone is adequate compared with
the pathology-based gold standard. Additional study by other co-
lonoscopists in different practice settings is warranted.
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